Abstract

The management of cervical cancer has undergone significant evolution, driven by advances in screening technologies, diagnostics, and surgical interventions. From the introduction of the Pap smear to the advent of HPV testing and vaccinations, early detection and prevention strategies have drastically reduced cervical cancer incidence in developed nations. Among the surgical approaches, cone biopsy has emerged as a critical procedure for both diagnosis and treatment in cases of early-stage cervical abnormalities. This article explores the progression of cervical cancer management, from screening to surgical interventions, with a focus on the role of cone biopsy as a cornerstone in modern gynecological oncology.